Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eurazeo SEEUZOF 58 Days Sales Outstanding is 183.77 as of Jun. 2026, which is 261% above its 10-year median of 50.97. GuruFocus rates EUZOF with a GF Score™ of 58/100 and a GF Value™ of $58.14 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 526 Asset Management companies, Eurazeo SE ranks worse than 86.31% on this metric.
Eurazeo SE's average Accounts Receivable for the
six
months ended in Jun. 2026 was $235.5 Mil. Eurazeo SE's Revenue for the
six
months ended in Jun. 2026 was $233.9 Mil.
Hence, Eurazeo SE's Days Sales Outstanding for the
six
months ended in Jun. 2026 was 183.77.
The historical rank and industry rank for Eurazeo SE's Days Sales Outstanding or its related term are showing as below:
EUZOF'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 34.5 Med: 50.97 Max: 502.5
Current: 182.18
During the past 13 years, Eurazeo SE's highest Days Sales Outstanding was 502.50. The lowest was 34.50. And the median was 50.97.
EUZOF's Days Sales Outstanding is ranked worse than 86.31% of 526
companies
in the Asset Management industry
Industry Median: 45.78
vs EUZOF: 182.18
Eurazeo SE's Days Sales Outstanding
declined
from Jun. 2025 (216.29) to Jun. 2026 (183.77).
Eurazeo SE (OTCPK:EUZOF) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Eurazeo SE Days Sales Outstanding Related Terms
Eurazeo SE Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Eurazeo SE's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EUZOF vs BLK, BX, KKR: Days Sales Outstanding Comparison
For the Asset Management subindustry, Eurazeo SE's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eurazeo SE Days Sales Outstanding vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Eurazeo SE's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Eurazeo SE's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 183.77 mean?
Eurazeo SE (EUZOF) has a Days Sales Outstanding of 183.77 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Eurazeo SE and its competitors. This is 261% above median its historical median of 50.97. Over the past decade, Eurazeo SE's Days Sales Outstanding has ranged from 34.50 to 502.50. According to the industry distribution chart, Eurazeo SE ranks #454 out of 526 companies in the Asset Management industry, placing it in the top 86.3%.
Is Eurazeo SE's Days Sales Outstanding too high?
Eurazeo SE's current Days Sales Outstanding of 183.77 is 261% above median its 10-year median of 50.97. Over the past 10 years, this metric has ranged from a low of 34.50 to a high of 502.50. The Asset Management industry median Days Sales Outstanding is 45.78. Eurazeo SE's value of 183.77 is 301.4% above this industry median. Based on the distribution chart, Eurazeo SE ranks #454 out of 526 companies in the Asset Management industry, which is in the bottom quartile relative to peers. Overall, Eurazeo SE has a GF Score™ of 58/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eurazeo SE's Days Sales Outstanding compare to BLK and BX?
According to the Asset Management industry distribution chart, Eurazeo SE ranks #454 out of 526 companies for Days Sales Outstanding. This places Eurazeo SE in the lower half of its industry. The industry median Days Sales Outstanding is 45.78. Eurazeo SE's value of 183.77 is 301.4% above this benchmark. Historically, Eurazeo SE's own Days Sales Outstanding has ranged from 34.50 to 502.50 over the past decade. While the company's 10-year median is 50.97 vs. the industry median of 45.78, Eurazeo SE has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for an Asset Management company?
The median Days Sales Outstanding among Asset Management companies is 45.78, based on 526 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eurazeo SE's current Days Sales Outstanding of 183.77 is 301.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Eurazeo SE and its competitors. For the Asset Management industry, the median Days Sales Outstanding is 45.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eurazeo SE's current Days Sales Outstanding is 183.77, which is 261% above median its own 10-year median of 50.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurazeo SE stock overvalued right now?
Based on GuruFocus' analysis, Eurazeo SE (EUZOF) is currently considered Modestly Undervalued. The stock's GF Value™ is $58.14, compared to a current price of $46.00 — trading 20.9% below its estimated fair value. The current Days Sales Outstanding is 183.77, which is 261% above median its 10-year median of 50.97 and 301.4% above the Asset Management industry median of 45.78. Eurazeo SE's overall GF Score™ is 58/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Eurazeo SE (EUZOF), the current Days Sales Outstanding is 183.77 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurazeo SE (EUZOF) Overvalued in 2026?
Based on GuruFocus' analysis, Eurazeo SE stock appears to be undervalued.
The current stock price of $46.00 is trading 20.9% below its estimated GF Value™ of $58.14.
GuruFocus considers Eurazeo SE to be Modestly Undervalued.
Key valuation signals for EUZOF:
Days Sales Outstanding: 183.77 (261% above median its 10-year median of 50.97)
GF Value™: $58.14 vs. price of $46.00 (20.9% below fair value)
Industry Position: 301.4% above the Asset Management median (#454 of 526)
No single metric tells the full story. See the EUZOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurazeo SE is an investment holding company operating as a conglomerate of four private equity segments. The company makes investments across a diverse array of industries and asset sizes, mostly in Europe. Eurazeo Capital, the company's greatest revenue contributor, makes investments in medium and large-sized companies above a certain asset threshold. Its other divisions consist of investments in small- and medium-sized companies, provide growth capital to smaller-sized enterprises, and make investments in real assets. The company is increasingly expanding into the Chinese, Brazilian, and American markets. Eurazeo measures performance by changes in net asset value.
58GF Score
Get the complete analysis for EUZOF
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EUZOF has been successfully added to your 
